China To Host World Environment Day 2019 On Air Pollution 15/03/2019 Editorial team As posted by UN Environment in a World Environment Day press release: Nairobi, 15 March 2019 – Today, the head of Chinese delegation, Zhao Yingmin, Vice Minister of Ecology and Environment, and Joyce Msuya, Acting Head of UN Environment, jointly announced that China will host the global World Environment Day celebrations on 5 June 2019 with a theme […] Continue reading -> ‘Netflix’ Pricing Model Eases Australians’ Access To Expensive Hepatitis C Drugs 14/02/2019 Elaine Ruth Fletcher An innovative five-year agreement between the Australian government and pharmaceutical companies, involving a lump sum payment of about US$ 766 million for an unlimited five-year supply of the most advanced Hepatitis C (HCV) drugs, has reduced the per-patient costs of these cutting-edge treatments by roughly 85%, according to a study today in the New England Journal of Medicine. Continue reading -> WHO Names Directors For Western Pacific, Southeast Asia 26/01/2019 William New The World Health Organization Executive Board today appointed the next directors for two of its its six regions. Continue reading -> Antibiotic R&D Group To Screen Pharma Chemical Libraries For Antibacterial Compounds 14/12/2018 David Branigan The Global Antibiotic Research and Development Partnership (GARDP) and the pharmaceutical companies Eisai and Takeda signed an agreement this week for GARDP to access and screen the chemical libraries of Eisai and Takeda with the hope of finding chemical compounds with antibacterial properties. Continue reading -> Surge In Demand Spurs Market-Opening Initiatives In China’s Healthcare Market 20/11/2018 John Zarocostas SHANGHAI, China - A surge in demand for better healthcare coverage and outcomes and widespread calls for a reduction in high medical treatment costs are driving structural reforms and market-opening initiatives in China's rapidly expanding healthcare market, industry executives, officials and experts have said. The market is forecast to increase from $761 billion in 2017 to nearly $2.4 trillion by 2030. Continue reading -> Asia-Pacific: Two Initiatives To Eliminate Malaria Once And For All 13/09/2018 Leila Ueberschlag For the first time in history, the elimination of malaria is within reach in the Asia Pacific, according to experts. The world is, indeed, witnessing unprecedented progress in the global effort to eliminate the disease. However, some challenges – such as a looming funding gap that threatens critical malaria-elimination – put at risk the recent improvement. Continue reading -> Hope For Hepatitis C Patients In Poor Countries – New Affordable Combination With High Cure Rate 12/04/2018 Catherine Saez A new affordable combination treatment for hepatitis C patients with a 97 percent cure rate was announced today. Continue reading -> Special Feature: Blocking Taiwan From Joining WHO Affects Global Health Security, Officials Say 09/04/2018 Catherine Saez TAIPEI, Taiwan - Two years after the victory of Taiwan Democratic Progressive Party (DPP) and President Tsai Ing-wen, Taiwan is feeling the effects of the DPP's position against the "One China principle." At the World Health Organization, China is allegedly successfully blocking Taiwan from participating in the annual World Health Assembly, and in a number of WHO technical meetings, officials say. Beyond the political dimension of the dissent between China and Taiwan, the situation may hurt the Taiwanese and global health security, Taiwanese officials said. Continue reading -> UAEM Students Launch Campaign To Drop Publicly Funded Patent Claim On Cancer Drug In India 16/03/2018 William New The Universities Allied for Essential Medicines (UAEM) this week launched a campaign to ask the University of California to drop its pursuit of a patent on the prostrate cancer drug Xtandi in India in order to make it affordable for patients. Xtandi sells at "exorbitant" rates in the United States, they said, a seeming violation of the licensing guidelines of the publicly funded University of California system which guarantees an "appropriate" return on taxpayer investments. Continue reading -> Indian Pharma Industry Disputes US Industry IP Index 15/02/2018 William New The United States Chamber of Commerce industry group recently issued its annual global IP index, analysing intellectual property protection in 50 countries, as a prelude to the annual US government list of countries seen as not adequately protection US companies' IP rights. Now an Indian industry group has issued a counter-statement to the Chamber index, calling it a "tirade" and "self-serving". Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
‘Netflix’ Pricing Model Eases Australians’ Access To Expensive Hepatitis C Drugs 14/02/2019 Elaine Ruth Fletcher An innovative five-year agreement between the Australian government and pharmaceutical companies, involving a lump sum payment of about US$ 766 million for an unlimited five-year supply of the most advanced Hepatitis C (HCV) drugs, has reduced the per-patient costs of these cutting-edge treatments by roughly 85%, according to a study today in the New England Journal of Medicine. Continue reading -> WHO Names Directors For Western Pacific, Southeast Asia 26/01/2019 William New The World Health Organization Executive Board today appointed the next directors for two of its its six regions. Continue reading -> Antibiotic R&D Group To Screen Pharma Chemical Libraries For Antibacterial Compounds 14/12/2018 David Branigan The Global Antibiotic Research and Development Partnership (GARDP) and the pharmaceutical companies Eisai and Takeda signed an agreement this week for GARDP to access and screen the chemical libraries of Eisai and Takeda with the hope of finding chemical compounds with antibacterial properties. Continue reading -> Surge In Demand Spurs Market-Opening Initiatives In China’s Healthcare Market 20/11/2018 John Zarocostas SHANGHAI, China - A surge in demand for better healthcare coverage and outcomes and widespread calls for a reduction in high medical treatment costs are driving structural reforms and market-opening initiatives in China's rapidly expanding healthcare market, industry executives, officials and experts have said. The market is forecast to increase from $761 billion in 2017 to nearly $2.4 trillion by 2030. Continue reading -> Asia-Pacific: Two Initiatives To Eliminate Malaria Once And For All 13/09/2018 Leila Ueberschlag For the first time in history, the elimination of malaria is within reach in the Asia Pacific, according to experts. The world is, indeed, witnessing unprecedented progress in the global effort to eliminate the disease. However, some challenges – such as a looming funding gap that threatens critical malaria-elimination – put at risk the recent improvement. Continue reading -> Hope For Hepatitis C Patients In Poor Countries – New Affordable Combination With High Cure Rate 12/04/2018 Catherine Saez A new affordable combination treatment for hepatitis C patients with a 97 percent cure rate was announced today. Continue reading -> Special Feature: Blocking Taiwan From Joining WHO Affects Global Health Security, Officials Say 09/04/2018 Catherine Saez TAIPEI, Taiwan - Two years after the victory of Taiwan Democratic Progressive Party (DPP) and President Tsai Ing-wen, Taiwan is feeling the effects of the DPP's position against the "One China principle." At the World Health Organization, China is allegedly successfully blocking Taiwan from participating in the annual World Health Assembly, and in a number of WHO technical meetings, officials say. Beyond the political dimension of the dissent between China and Taiwan, the situation may hurt the Taiwanese and global health security, Taiwanese officials said. Continue reading -> UAEM Students Launch Campaign To Drop Publicly Funded Patent Claim On Cancer Drug In India 16/03/2018 William New The Universities Allied for Essential Medicines (UAEM) this week launched a campaign to ask the University of California to drop its pursuit of a patent on the prostrate cancer drug Xtandi in India in order to make it affordable for patients. Xtandi sells at "exorbitant" rates in the United States, they said, a seeming violation of the licensing guidelines of the publicly funded University of California system which guarantees an "appropriate" return on taxpayer investments. Continue reading -> Indian Pharma Industry Disputes US Industry IP Index 15/02/2018 William New The United States Chamber of Commerce industry group recently issued its annual global IP index, analysing intellectual property protection in 50 countries, as a prelude to the annual US government list of countries seen as not adequately protection US companies' IP rights. Now an Indian industry group has issued a counter-statement to the Chamber index, calling it a "tirade" and "self-serving". Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
WHO Names Directors For Western Pacific, Southeast Asia 26/01/2019 William New The World Health Organization Executive Board today appointed the next directors for two of its its six regions. Continue reading -> Antibiotic R&D Group To Screen Pharma Chemical Libraries For Antibacterial Compounds 14/12/2018 David Branigan The Global Antibiotic Research and Development Partnership (GARDP) and the pharmaceutical companies Eisai and Takeda signed an agreement this week for GARDP to access and screen the chemical libraries of Eisai and Takeda with the hope of finding chemical compounds with antibacterial properties. Continue reading -> Surge In Demand Spurs Market-Opening Initiatives In China’s Healthcare Market 20/11/2018 John Zarocostas SHANGHAI, China - A surge in demand for better healthcare coverage and outcomes and widespread calls for a reduction in high medical treatment costs are driving structural reforms and market-opening initiatives in China's rapidly expanding healthcare market, industry executives, officials and experts have said. The market is forecast to increase from $761 billion in 2017 to nearly $2.4 trillion by 2030. Continue reading -> Asia-Pacific: Two Initiatives To Eliminate Malaria Once And For All 13/09/2018 Leila Ueberschlag For the first time in history, the elimination of malaria is within reach in the Asia Pacific, according to experts. The world is, indeed, witnessing unprecedented progress in the global effort to eliminate the disease. However, some challenges – such as a looming funding gap that threatens critical malaria-elimination – put at risk the recent improvement. Continue reading -> Hope For Hepatitis C Patients In Poor Countries – New Affordable Combination With High Cure Rate 12/04/2018 Catherine Saez A new affordable combination treatment for hepatitis C patients with a 97 percent cure rate was announced today. Continue reading -> Special Feature: Blocking Taiwan From Joining WHO Affects Global Health Security, Officials Say 09/04/2018 Catherine Saez TAIPEI, Taiwan - Two years after the victory of Taiwan Democratic Progressive Party (DPP) and President Tsai Ing-wen, Taiwan is feeling the effects of the DPP's position against the "One China principle." At the World Health Organization, China is allegedly successfully blocking Taiwan from participating in the annual World Health Assembly, and in a number of WHO technical meetings, officials say. Beyond the political dimension of the dissent between China and Taiwan, the situation may hurt the Taiwanese and global health security, Taiwanese officials said. Continue reading -> UAEM Students Launch Campaign To Drop Publicly Funded Patent Claim On Cancer Drug In India 16/03/2018 William New The Universities Allied for Essential Medicines (UAEM) this week launched a campaign to ask the University of California to drop its pursuit of a patent on the prostrate cancer drug Xtandi in India in order to make it affordable for patients. Xtandi sells at "exorbitant" rates in the United States, they said, a seeming violation of the licensing guidelines of the publicly funded University of California system which guarantees an "appropriate" return on taxpayer investments. Continue reading -> Indian Pharma Industry Disputes US Industry IP Index 15/02/2018 William New The United States Chamber of Commerce industry group recently issued its annual global IP index, analysing intellectual property protection in 50 countries, as a prelude to the annual US government list of countries seen as not adequately protection US companies' IP rights. Now an Indian industry group has issued a counter-statement to the Chamber index, calling it a "tirade" and "self-serving". Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Antibiotic R&D Group To Screen Pharma Chemical Libraries For Antibacterial Compounds 14/12/2018 David Branigan The Global Antibiotic Research and Development Partnership (GARDP) and the pharmaceutical companies Eisai and Takeda signed an agreement this week for GARDP to access and screen the chemical libraries of Eisai and Takeda with the hope of finding chemical compounds with antibacterial properties. Continue reading -> Surge In Demand Spurs Market-Opening Initiatives In China’s Healthcare Market 20/11/2018 John Zarocostas SHANGHAI, China - A surge in demand for better healthcare coverage and outcomes and widespread calls for a reduction in high medical treatment costs are driving structural reforms and market-opening initiatives in China's rapidly expanding healthcare market, industry executives, officials and experts have said. The market is forecast to increase from $761 billion in 2017 to nearly $2.4 trillion by 2030. Continue reading -> Asia-Pacific: Two Initiatives To Eliminate Malaria Once And For All 13/09/2018 Leila Ueberschlag For the first time in history, the elimination of malaria is within reach in the Asia Pacific, according to experts. The world is, indeed, witnessing unprecedented progress in the global effort to eliminate the disease. However, some challenges – such as a looming funding gap that threatens critical malaria-elimination – put at risk the recent improvement. Continue reading -> Hope For Hepatitis C Patients In Poor Countries – New Affordable Combination With High Cure Rate 12/04/2018 Catherine Saez A new affordable combination treatment for hepatitis C patients with a 97 percent cure rate was announced today. Continue reading -> Special Feature: Blocking Taiwan From Joining WHO Affects Global Health Security, Officials Say 09/04/2018 Catherine Saez TAIPEI, Taiwan - Two years after the victory of Taiwan Democratic Progressive Party (DPP) and President Tsai Ing-wen, Taiwan is feeling the effects of the DPP's position against the "One China principle." At the World Health Organization, China is allegedly successfully blocking Taiwan from participating in the annual World Health Assembly, and in a number of WHO technical meetings, officials say. Beyond the political dimension of the dissent between China and Taiwan, the situation may hurt the Taiwanese and global health security, Taiwanese officials said. Continue reading -> UAEM Students Launch Campaign To Drop Publicly Funded Patent Claim On Cancer Drug In India 16/03/2018 William New The Universities Allied for Essential Medicines (UAEM) this week launched a campaign to ask the University of California to drop its pursuit of a patent on the prostrate cancer drug Xtandi in India in order to make it affordable for patients. Xtandi sells at "exorbitant" rates in the United States, they said, a seeming violation of the licensing guidelines of the publicly funded University of California system which guarantees an "appropriate" return on taxpayer investments. Continue reading -> Indian Pharma Industry Disputes US Industry IP Index 15/02/2018 William New The United States Chamber of Commerce industry group recently issued its annual global IP index, analysing intellectual property protection in 50 countries, as a prelude to the annual US government list of countries seen as not adequately protection US companies' IP rights. Now an Indian industry group has issued a counter-statement to the Chamber index, calling it a "tirade" and "self-serving". Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Surge In Demand Spurs Market-Opening Initiatives In China’s Healthcare Market 20/11/2018 John Zarocostas SHANGHAI, China - A surge in demand for better healthcare coverage and outcomes and widespread calls for a reduction in high medical treatment costs are driving structural reforms and market-opening initiatives in China's rapidly expanding healthcare market, industry executives, officials and experts have said. The market is forecast to increase from $761 billion in 2017 to nearly $2.4 trillion by 2030. Continue reading -> Asia-Pacific: Two Initiatives To Eliminate Malaria Once And For All 13/09/2018 Leila Ueberschlag For the first time in history, the elimination of malaria is within reach in the Asia Pacific, according to experts. The world is, indeed, witnessing unprecedented progress in the global effort to eliminate the disease. However, some challenges – such as a looming funding gap that threatens critical malaria-elimination – put at risk the recent improvement. Continue reading -> Hope For Hepatitis C Patients In Poor Countries – New Affordable Combination With High Cure Rate 12/04/2018 Catherine Saez A new affordable combination treatment for hepatitis C patients with a 97 percent cure rate was announced today. Continue reading -> Special Feature: Blocking Taiwan From Joining WHO Affects Global Health Security, Officials Say 09/04/2018 Catherine Saez TAIPEI, Taiwan - Two years after the victory of Taiwan Democratic Progressive Party (DPP) and President Tsai Ing-wen, Taiwan is feeling the effects of the DPP's position against the "One China principle." At the World Health Organization, China is allegedly successfully blocking Taiwan from participating in the annual World Health Assembly, and in a number of WHO technical meetings, officials say. Beyond the political dimension of the dissent between China and Taiwan, the situation may hurt the Taiwanese and global health security, Taiwanese officials said. Continue reading -> UAEM Students Launch Campaign To Drop Publicly Funded Patent Claim On Cancer Drug In India 16/03/2018 William New The Universities Allied for Essential Medicines (UAEM) this week launched a campaign to ask the University of California to drop its pursuit of a patent on the prostrate cancer drug Xtandi in India in order to make it affordable for patients. Xtandi sells at "exorbitant" rates in the United States, they said, a seeming violation of the licensing guidelines of the publicly funded University of California system which guarantees an "appropriate" return on taxpayer investments. Continue reading -> Indian Pharma Industry Disputes US Industry IP Index 15/02/2018 William New The United States Chamber of Commerce industry group recently issued its annual global IP index, analysing intellectual property protection in 50 countries, as a prelude to the annual US government list of countries seen as not adequately protection US companies' IP rights. Now an Indian industry group has issued a counter-statement to the Chamber index, calling it a "tirade" and "self-serving". Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Asia-Pacific: Two Initiatives To Eliminate Malaria Once And For All 13/09/2018 Leila Ueberschlag For the first time in history, the elimination of malaria is within reach in the Asia Pacific, according to experts. The world is, indeed, witnessing unprecedented progress in the global effort to eliminate the disease. However, some challenges – such as a looming funding gap that threatens critical malaria-elimination – put at risk the recent improvement. Continue reading -> Hope For Hepatitis C Patients In Poor Countries – New Affordable Combination With High Cure Rate 12/04/2018 Catherine Saez A new affordable combination treatment for hepatitis C patients with a 97 percent cure rate was announced today. Continue reading -> Special Feature: Blocking Taiwan From Joining WHO Affects Global Health Security, Officials Say 09/04/2018 Catherine Saez TAIPEI, Taiwan - Two years after the victory of Taiwan Democratic Progressive Party (DPP) and President Tsai Ing-wen, Taiwan is feeling the effects of the DPP's position against the "One China principle." At the World Health Organization, China is allegedly successfully blocking Taiwan from participating in the annual World Health Assembly, and in a number of WHO technical meetings, officials say. Beyond the political dimension of the dissent between China and Taiwan, the situation may hurt the Taiwanese and global health security, Taiwanese officials said. Continue reading -> UAEM Students Launch Campaign To Drop Publicly Funded Patent Claim On Cancer Drug In India 16/03/2018 William New The Universities Allied for Essential Medicines (UAEM) this week launched a campaign to ask the University of California to drop its pursuit of a patent on the prostrate cancer drug Xtandi in India in order to make it affordable for patients. Xtandi sells at "exorbitant" rates in the United States, they said, a seeming violation of the licensing guidelines of the publicly funded University of California system which guarantees an "appropriate" return on taxpayer investments. Continue reading -> Indian Pharma Industry Disputes US Industry IP Index 15/02/2018 William New The United States Chamber of Commerce industry group recently issued its annual global IP index, analysing intellectual property protection in 50 countries, as a prelude to the annual US government list of countries seen as not adequately protection US companies' IP rights. Now an Indian industry group has issued a counter-statement to the Chamber index, calling it a "tirade" and "self-serving". Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Hope For Hepatitis C Patients In Poor Countries – New Affordable Combination With High Cure Rate 12/04/2018 Catherine Saez A new affordable combination treatment for hepatitis C patients with a 97 percent cure rate was announced today. Continue reading -> Special Feature: Blocking Taiwan From Joining WHO Affects Global Health Security, Officials Say 09/04/2018 Catherine Saez TAIPEI, Taiwan - Two years after the victory of Taiwan Democratic Progressive Party (DPP) and President Tsai Ing-wen, Taiwan is feeling the effects of the DPP's position against the "One China principle." At the World Health Organization, China is allegedly successfully blocking Taiwan from participating in the annual World Health Assembly, and in a number of WHO technical meetings, officials say. Beyond the political dimension of the dissent between China and Taiwan, the situation may hurt the Taiwanese and global health security, Taiwanese officials said. Continue reading -> UAEM Students Launch Campaign To Drop Publicly Funded Patent Claim On Cancer Drug In India 16/03/2018 William New The Universities Allied for Essential Medicines (UAEM) this week launched a campaign to ask the University of California to drop its pursuit of a patent on the prostrate cancer drug Xtandi in India in order to make it affordable for patients. Xtandi sells at "exorbitant" rates in the United States, they said, a seeming violation of the licensing guidelines of the publicly funded University of California system which guarantees an "appropriate" return on taxpayer investments. Continue reading -> Indian Pharma Industry Disputes US Industry IP Index 15/02/2018 William New The United States Chamber of Commerce industry group recently issued its annual global IP index, analysing intellectual property protection in 50 countries, as a prelude to the annual US government list of countries seen as not adequately protection US companies' IP rights. Now an Indian industry group has issued a counter-statement to the Chamber index, calling it a "tirade" and "self-serving". Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Special Feature: Blocking Taiwan From Joining WHO Affects Global Health Security, Officials Say 09/04/2018 Catherine Saez TAIPEI, Taiwan - Two years after the victory of Taiwan Democratic Progressive Party (DPP) and President Tsai Ing-wen, Taiwan is feeling the effects of the DPP's position against the "One China principle." At the World Health Organization, China is allegedly successfully blocking Taiwan from participating in the annual World Health Assembly, and in a number of WHO technical meetings, officials say. Beyond the political dimension of the dissent between China and Taiwan, the situation may hurt the Taiwanese and global health security, Taiwanese officials said. Continue reading -> UAEM Students Launch Campaign To Drop Publicly Funded Patent Claim On Cancer Drug In India 16/03/2018 William New The Universities Allied for Essential Medicines (UAEM) this week launched a campaign to ask the University of California to drop its pursuit of a patent on the prostrate cancer drug Xtandi in India in order to make it affordable for patients. Xtandi sells at "exorbitant" rates in the United States, they said, a seeming violation of the licensing guidelines of the publicly funded University of California system which guarantees an "appropriate" return on taxpayer investments. Continue reading -> Indian Pharma Industry Disputes US Industry IP Index 15/02/2018 William New The United States Chamber of Commerce industry group recently issued its annual global IP index, analysing intellectual property protection in 50 countries, as a prelude to the annual US government list of countries seen as not adequately protection US companies' IP rights. Now an Indian industry group has issued a counter-statement to the Chamber index, calling it a "tirade" and "self-serving". Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
UAEM Students Launch Campaign To Drop Publicly Funded Patent Claim On Cancer Drug In India 16/03/2018 William New The Universities Allied for Essential Medicines (UAEM) this week launched a campaign to ask the University of California to drop its pursuit of a patent on the prostrate cancer drug Xtandi in India in order to make it affordable for patients. Xtandi sells at "exorbitant" rates in the United States, they said, a seeming violation of the licensing guidelines of the publicly funded University of California system which guarantees an "appropriate" return on taxpayer investments. Continue reading -> Indian Pharma Industry Disputes US Industry IP Index 15/02/2018 William New The United States Chamber of Commerce industry group recently issued its annual global IP index, analysing intellectual property protection in 50 countries, as a prelude to the annual US government list of countries seen as not adequately protection US companies' IP rights. Now an Indian industry group has issued a counter-statement to the Chamber index, calling it a "tirade" and "self-serving". Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Indian Pharma Industry Disputes US Industry IP Index 15/02/2018 William New The United States Chamber of Commerce industry group recently issued its annual global IP index, analysing intellectual property protection in 50 countries, as a prelude to the annual US government list of countries seen as not adequately protection US companies' IP rights. Now an Indian industry group has issued a counter-statement to the Chamber index, calling it a "tirade" and "self-serving". Continue reading -> Posts navigation Older postsNewer posts